Biblio
Found 2636 results
Author [ Keyword![(Asc)](https://www.niagads.org/sites/all/modules/contrib/biblio/misc/arrow-asc.png)
Filters: First Letter Of Last Name is R [Clear All Filters]
“Differential modulation of endotoxin responsiveness by human caspase-12 polymorphisms.”, Nature, vol. 429, no. 6987, pp. 75-9, 2004.
, “HAMR: high-throughput annotation of modified ribonucleotides.”, RNA, vol. 19, no. 12, pp. 1684-92, 2013.
, “HAMR: high-throughput annotation of modified ribonucleotides.”, RNA, vol. 19, no. 12, pp. 1684-92, 2013.
, “Using machine learning and high-throughput RNA sequencing to classify the precursors of small non-coding RNAs.”, Methods, vol. 67, no. 1, pp. 28-35, 2014.
, “CoRAL: predicting non-coding RNAs from small RNA-sequencing data.”, Nucleic Acids Res, vol. 41, no. 14, p. e137, 2013.
, “Transcriptomic Changes Due to Cytoplasmic TDP-43 Expression Reveal Dysregulation of Histone Transcripts and Nuclear Chromatin.”, PLoS One, vol. 10, no. 10, p. e0141836, 2015.
, “Using machine learning and high-throughput RNA sequencing to classify the precursors of small non-coding RNAs.”, Methods, vol. 67, no. 1, pp. 28-35, 2014.
, “HAMR: high-throughput annotation of modified ribonucleotides.”, RNA, vol. 19, no. 12, pp. 1684-92, 2013.
, “Brain expression genome-wide association study (eGWAS) identifies human disease-associated variants.”, PLoS Genet, vol. 8, no. 6, p. e1002707, 2012.
, “HAMR: high-throughput annotation of modified ribonucleotides.”, RNA, vol. 19, no. 12, pp. 1684-92, 2013.
, “A common haplotype lowers PU.1 expression in myeloid cells and delays onset of Alzheimer's disease.”, Nat Neurosci, vol. 20, no. 8, pp. 1052-1061, 2017.
, “A common haplotype lowers PU.1 expression in myeloid cells and delays onset of Alzheimer's disease.”, Nat Neurosci, vol. 20, no. 8, pp. 1052-1061, 2017.
, “GAB2 alleles modify Alzheimer's risk in APOE epsilon4 carriers.”, Neuron, vol. 54, no. 5, pp. 713-20, 2007.
, “GAB2 alleles modify Alzheimer's risk in APOE epsilon4 carriers.”, Neuron, vol. 54, no. 5, pp. 713-20, 2007.
, “GAB2 alleles modify Alzheimer's risk in APOE epsilon4 carriers.”, Neuron, vol. 54, no. 5, pp. 713-20, 2007.
, “GAB2 alleles modify Alzheimer's risk in APOE epsilon4 carriers.”, Neuron, vol. 54, no. 5, pp. 713-20, 2007.
, “Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study.”, JAMA Neurol, vol. 71, no. 11, pp. 1394-404, 2014.
, “Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study.”, JAMA Neurol, vol. 71, no. 11, pp. 1394-404, 2014.
, “Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy.”, Nat Genet, vol. 43, no. 7, pp. 699-705, 2011.
, “An epigenetic signature in peripheral blood associated with the haplotype on 17q21.31, a risk factor for neurodegenerative tauopathy.”, PLoS Genet, vol. 10, no. 3, p. e1004211, 2014.
, “Independent and epistatic effects of variants in VPS10-d receptors on Alzheimer disease risk and processing of the amyloid precursor protein (APP).”, Transl Psychiatry, vol. 3, p. e256, 2013.
, “Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study.”, JAMA Neurol, vol. 71, no. 11, pp. 1394-404, 2014.
, “Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy.”, Nat Genet, vol. 43, no. 7, pp. 699-705, 2011.
, “Independent and epistatic effects of variants in VPS10-d receptors on Alzheimer disease risk and processing of the amyloid precursor protein (APP).”, Transl Psychiatry, vol. 3, p. e256, 2013.
, “Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study.”, JAMA Neurol, vol. 71, no. 11, pp. 1394-404, 2014.
,